Dolutegravir

[reference-standards] Dolutegravir
  • Product number: C4672
  • CAS number: 1051375-16-6
  • Molecular formula: C20H19F2N3O5
  • Molecular weight: 419,38 g.mol-1
  • Min. purity: 98,00 %
  • Solubility: refer to COA
  • Stability: ≥ 1 year
  • Shipping: 24/48h for products in stock
Make a request
Product Number: C4672
Size
Qty

Description

Dolutegravir is intended for Pharmaceuticals applications. Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. All information about Dolutegravir is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

Related products

References

  1. A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva Journal of Antimicrobial Chemotherapy, Volume 76, Issue 2, February 2021, Pages 423–429, [...]
  2. HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-ß-d-glucuronide in human plasma Journal of Pharmaceutical and Biomedical Analysis Volume 182, 15 April 2020, 113119 [...]

Recommendation